h-89 and Status-Epilepticus

h-89 has been researched along with Status-Epilepticus* in 1 studies

Other Studies

1 other study(ies) available for h-89 and Status-Epilepticus

ArticleYear
Leptomycin B attenuates neuronal death via PKA- and PP2B-mediated ERK1/2 activation in the rat hippocampus following status epilepticus.
    Brain research, 2017, Sep-01, Volume: 1670

    Leptomycin B (LMB), originally developed as an anti-fungal agent, has potent neuroprotective properties against status epilepticus (SE, a prolonged seizure activity). However, the pharmacological profiles and mechanisms of LMB for neuroprotection remain elusive. In the present study, we found that LMB increased phosphorylation levels of protein kinase A (PKA) catalytic subunits, protein phosphatase 2B (PP2B, calcineurin) and extracellular signal-regulated kinase 1/2 (ERK1/2) under normal condition, and abolished SE-induced neuronal death. Co-treatment of H-89 (a PKA inhibitor) with LMB could not affect the seizure latency and its severity in response to pilocarpine. However, H-89 co-treatment abrogated the protective effect of LMB on SE-induced neuronal damage. Cyclosporin A (CsA, a PP2B inhibitor) co-treatment effectively prevented SE-induced neuronal death without altered seizure susceptibility in response to pilocarpine more than LMB alone. H-89 co-treatment inhibited LMB-mediated ERK1/2 phosphorylation, but CsA enhanced it. U0126 (an ERK1/2 inhibitor) co-treatment abolished the protective effect of LMB on SE-induced neuronal death without alterations in PKA and PP2B phosphorylations. To the best of our knowledge, the present data demonstrate a previously unreported potential neuroprotective role of LMB against SE via PKA- and PP2B-mediated ERK1/2 activation.

    Topics: Animals; Calcineurin; Cell Death; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Disease Models, Animal; Fatty Acids, Unsaturated; Hippocampus; Isoquinolines; Male; MAP Kinase Signaling System; Neurons; Neuroprotective Agents; Phosphorylation; Rats; Rats, Sprague-Dawley; Seizures; Status Epilepticus; Sulfonamides; Temporal Lobe

2017